Xu Ding

机构：First People’s Hospital of Jingmen, Jingchu University of Technology · ORCID：0000-0002-0882-8078

发表论文 69 篇 · 总被引 2339 次 · h-index 24

代表论文

• Antisense oligonucleotides targeting lncRNA AC104041.1 induces antitumor activity through Wnt2B/β-catenin pathway in head and neck squamous cell carcinomas (2020 · Cell Death and Disease · 被引 80)
• TNFAIP2 confers cisplatin resistance in head and neck squamous cell carcinoma via KEAP1/NRF2 signaling (2023 · Journal of Experimental & Clinical Cancer Research · 被引 43)
• Immune landscape and subtypes in primary resectable oral squamous cell carcinoma: prognostic significance and predictive of therapeutic response (2021 · Journal for ImmunoTherapy of Cancer · 被引 34)
• The Endoplasmic Reticulum-Stressed Head and Neck Squamous Cell Carcinoma Cells Induced Exosomal miR-424-5p Inhibits Angiogenesis and Migration of Humanumbilical Vein Endothelial Cells Through LAMC1-Mediated Wnt/β-Catenin Signaling Pathway (2022 · Cell Transplantation · 被引 22)
• EZH2 is associated with cartilage degeneration in osteoarthritis by promoting SDC1 expression via histone methylation of the microRNA-138 promoter (2021 · Laboratory Investigation · 被引 22)
• Regulation of Semaphorin3A in the process of cutaneous wound healing (2022 · Cell Death and Differentiation · 被引 21)